---
title: "Sichuan Hebang Biotechnology Co.,Ltd. (603077.SH)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/603077.SH.md"
symbol: "603077.SH"
name: "Sichuan Hebang Biotechnology Co.,Ltd."
industry: "Commodity Chemicals"
datetime: "2026-04-30T23:17:52.613Z"
locales:
  - [en](https://longbridge.com/en/quote/603077.SH.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/603077.SH.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/603077.SH.md)
---

# Sichuan Hebang Biotechnology Co.,Ltd. (603077.SH)

## Company Overview

Sichuan Hebang Biotechnology Corporation Limited provides agricultural, chemical, and new material products. It offers biological pesticides, biological veterinary drugs, and methionine products; and sodium carbonate, ammonium chloride, soda ash, diglyphosate, glyphosate, and brine. The company provides original glass and smart glass, special glass, low-e coated glass, and photovoltaic packaging materials and products, as well as photovoltaic glass and module products. In addition, it engages in the supply of oil and gas.

| Item | Detail |
|------|--------|
| Industry | Commodity Chemicals |
| Exchange | CN Market |
| Website | [www.hebang.cn](https://www.hebang.cn) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: D
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-04-30T04:30:13.000Z

**Overall: D (0.75)**

**Industry**: Commodity Chemicals

| Metric | Value |
|--------|-------|
| Industry Ranking | 225 / 271 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Mid - The company has stable operation of a large-cap stock and the high return of a small-cap stock.

**Multi Score**: D

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -17.21% |  |
| Net Profit YoY | -2745.17% |  |
| P/B Ratio | 1.51 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 26851111297.39 |  |
| Revenue | 6850302998.19 |  |

#### Multi Score Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 0.00% | D |
| Profit Margin | 0.00% | D |
| Gross Margin | 24.37% | C |
| Revenue YoY | -17.21% | E |
| Net Profit YoY | -2745.17% | E |
| Total Assets YoY | -3.77% | D |
| Net Assets YoY | -2.90% | D |
| Cash Flow Margin | -307.31% | E |
| OCF YoY | -17.21% | E |
| Turnover | 0.00 | E |
| Gearing Ratio | 36.69% | B |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Sichuan Hebang Biotechnology Co.,Ltd.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-17.21%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "-2745.17%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "1.51",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "26851111297.39",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "6850302998.19",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "D",
      "indicators": [
        {
          "name": "ROE",
          "value": "0.00%",
          "rating": "D"
        },
        {
          "name": "Profit Margin",
          "value": "0.00%",
          "rating": "D"
        },
        {
          "name": "Gross Margin",
          "value": "24.37%",
          "rating": "C"
        },
        {
          "name": "Revenue YoY",
          "value": "-17.21%",
          "rating": "E"
        },
        {
          "name": "Net Profit YoY",
          "value": "-2745.17%",
          "rating": "E"
        },
        {
          "name": "Total Assets YoY",
          "value": "-3.77%",
          "rating": "D"
        },
        {
          "name": "Net Assets YoY",
          "value": "-2.90%",
          "rating": "D"
        },
        {
          "name": "Cash Flow Margin",
          "value": "-307.31%",
          "rating": "E"
        },
        {
          "name": "OCF YoY",
          "value": "-17.21%",
          "rating": "E"
        },
        {
          "name": "Turnover",
          "value": "0.00",
          "rating": "E"
        },
        {
          "name": "Gearing Ratio",
          "value": "36.69%",
          "rating": "B"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -69.65 | 256/271 | 1170.09 | 1107.84 | 1082.96 |
| PB | 1.47 | 35/271 | 1.25 | 1.06 | 0.88 |
| PS (TTM) | 3.82 | 167/271 | 2.96 | 2.50 | 1.92 |
| Dividend Yield | 0.00% | - | 1.03% | 0.97% | 0.93% |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Sanmei (603379.SH) | A | A | B | A | B | A |
| 02 | TINCI (002709.SZ) | B | A | B | B | B | B |
| 03 | Grace (603256.SH) | A | A | C | B | B | B |
| 04 | ZJJH (600160.SH) | B | B | B | B | B | B |
| 05 | SINOMATECH (002080.SZ) | B | B | C | D | B | B |

## Institutional View

### Analyst Rating Distribution

> As of 2022-05-18T16:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 1 | 100% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 2.96 |
| Highest Target | undefined |
| Lowest Target | undefined |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/603077.SH/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/603077.SH/norm.md)
- [Related News](https://longbridge.com/en/quote/603077.SH/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/603077.SH/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**